The Brown School’s Jason Purnell will lead a response team of over 40 St. Louis area nonprofits, social service agencies and governments to deal with the coronavirus pandemic.
Washington University School of Medicine in St. Louis is launching a clinical trial for patients hospitalized with COVID-19 at Barnes-Jewish Hospital. The trial will investigate the effectiveness of different combinations of the antimalarial drugs chloroquine and hydroxychloroquine and the antibiotic azithromycin in treating ill patients infected with the novel coronavirus.
Washington University Institute of Clinical and Translational Sciences (ICTS) awards 24 investigators with grants as part of the 13th annual Clinical and Translational Research Funding Program (CTRFP). The CTRFP is the largest internal grant funding program of the ICTS. Grant awardees are required to submit projects for funding that promote the translation of scientific discoveries […]
The Washington University Institute of Clinical and Translational Sciences and Washington University’s Institute for Public Health announce six partnerships selected to receive funding through the new Partnership Development and Sustainability Support (PDSS) program. This funding program provides up to $10,000 to community-academic partnerships for a 12-month period. It enables partners to develop the trust, infrastructure, […]
For the ICTS, Valentine’s Day was all about the love of informatics. On February 14, the ICTS hosted their third annual Symposium and Poster Session held at the Eric P. Newman Education Center on the campus of Washington University School of Medicine in St. Louis. The day-long event featured presentations, breakout discussions, and a poster […]
Breakthrough research is rarely accomplished in a vacuum. Years of training, time spent writing and countless hours coordinating resources is an inherent part of any researcher’s work on the path to a successful study. Such is the case for Stephanie Fritz, MD, MSCI, ICTS member and senior author of a new study on how the […]
Qualitative data—such as data from interview or focus group studies—has a unique value in understanding health behaviors and traits. It is often used to understand attitudes and preferences, as well as complex and hidden behaviors. Qualitative research has led to deeper understandings of risk factors for HIV, teen pregnancy, and illegal drug use. When participants […]
David Holtzman, MD,has received the August M. Watanabe Prize in Translational Research from the Indiana Clinical and Translational Sciences Institute.
Rare diseases by definition afflict a limited amount of people. However, according to the National Center for Advancing Translational Sciences (NCATS), the collective impact of rare diseases affect an estimated 30 million people in the United States. As part of the CTSA program, the ICTS is working to engage patients and communities around rare disease. […]
ICTS member scientific productivity in 2017 1,662 ICTS members (75% of active members) published in 2017, resulting in 4,450 publications.